1. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours. (25th October 2014) Authors: Queiroga, F. L.; Pérez‐Alenza, M. D.; González Gil, A.; Silvan, G.; Peña, L.; Illera, J. C. Journal: Veterinary record Issue: Volume 175:Number 16(2014) Page Start: 403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours. (17th January 2016) Authors: Raposo, T. P.; Pires, I.; Prada, J.; Queiroga, F. L.; Argyle, D. J. Journal: Veterinary and comparative oncology Issue: Volume 15:Number 2(2017:Jun.) Page Start: 655 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High COX‐2 expression in canine mast cell tumours is associated with proliferation, angiogenesis and decreased overall survival. (7th November 2016) Authors: Gregório, H.; Raposo, T.; Queiroga, F. L.; Pires, I.; Pena, L.; Prada, J. Journal: Veterinary and comparative oncology Issue: Volume 15:Number 4(2017:Dec.) Page Start: 1382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High COX‐2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study. (21st January 2016) Authors: Carvalho, M. I.; Pires, I.; Prada, J.; Raposo, T. P.; Gregório, H.; Lobo, L.; Queiroga, F. L. Journal: Veterinary and comparative oncology Issue: Volume 15:Number 2(2017:Jun.) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis. (November 2016) Authors: Carvalho, M. I.; Pires, I.; Prada, J.; Lobo, L.; Queiroga, F. L. Journal: Veterinary pathology Issue: Volume 53:Number 6(2016:Nov.) Page Start: 1138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic value of tumour‐associated macrophages in canine mammary tumours. (26th April 2012) Authors: Raposo, T.; Gregório, H.; Pires, I.; Prada, J.; Queiroga, F. L. Journal: Veterinary and comparative oncology Issue: Volume 12:Number 1(2014:Mar.) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications. (14th October 2015) Authors: Queiroga, F. L.; Perez‐Alenza, M. D.; González‐Gil, A.; Silván, G.; Peña, L.; Illera, J. C. Journal: Veterinary and comparative oncology Issue: Volume 15:Number 2(2017:Jun.) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The use of low‐dose metronomic chemotherapy in dogs—insight into a modern cancer field. (20th March 2017) Authors: Gaspar, T. B.; Henriques, J.; Marconato, L.; Queiroga, F. L. Journal: Veterinary and comparative oncology Issue: Volume 16:Number 1(2018:Mar.) Page Start: 2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tumour‐associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours. (4th October 2013) Authors: Raposo, T. P.; Pires, I.; Carvalho, M. I.; Prada, J.; Argyle, D. J.; Queiroga, F. L. Journal: Veterinary and comparative oncology Issue: Volume 13:Number 4(2015:Dec.) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗